110 related articles for article (PubMed ID: 16223002)
1. [Mitotic activity in serous adenocarcinoma of the uterine body].
Vasil'eva EV; Belianin VL
Vopr Onkol; 2005; 51(2):206-10. PubMed ID: 16223002
[TBL] [Abstract][Full Text] [Related]
2. Metastatic uterine serous carcinoma originating in an endometrial polyp: a report of 2 cases.
Childs AJ; Burke JJ; Perry MY; Gallup DG
J Reprod Med; 2005 Mar; 50(3):209-12. PubMed ID: 15841935
[TBL] [Abstract][Full Text] [Related]
3. Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas.
Siami K; McCluggage WG; Ordonez NG; Euscher ED; Malpica A; Sneige N; Silva EG; Deavers MT
Am J Surg Pathol; 2007 Nov; 31(11):1759-63. PubMed ID: 18059234
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of preoperative endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma.
Leitao MM; Kehoe S; Barakat RR; Alektiar K; Gattoc LP; Rabbitt C; Chi DS; Soslow RA; Abu-Rustum NR
Gynecol Oncol; 2008 Nov; 111(2):244-8. PubMed ID: 18752842
[TBL] [Abstract][Full Text] [Related]
5. Synchronous ovarian granulosa cell tumor and uterine serous carcinoma: a rare association of a high-risk endometrial cancer with anestrogenic ovarian tumor.
Rabban JT; Gupta D; Zaloudek CJ; Chen LM
Gynecol Oncol; 2006 Dec; 103(3):1164-8. PubMed ID: 17034837
[TBL] [Abstract][Full Text] [Related]
6. [Nucleolar organizers and mitotic conditions in endometrial hyperplasia and carcinomaĭ].
Ellinidi VN; Pozharisskii KM
Vopr Onkol; 1999; 45(6):636-40. PubMed ID: 10703512
[TBL] [Abstract][Full Text] [Related]
7. p16 expression in the female genital tract and its value in diagnosis.
O'Neill CJ; McCluggage WG
Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
[TBL] [Abstract][Full Text] [Related]
8. Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high-grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases.
Han G; Gilks CB; Leung S; Ewanowich CA; Irving JA; Longacre TA; Soslow RA
Am J Surg Pathol; 2008 Jul; 32(7):955-64. PubMed ID: 18460981
[TBL] [Abstract][Full Text] [Related]
9. [Mitotic conditions in primary and metastatic nodes of breast and cervix cancer].
Ermolenko LM
Arkh Patol; 1979; 41(8):50-3. PubMed ID: 485886
[TBL] [Abstract][Full Text] [Related]
10. [Relation between the proliferative activity of cancer of the endometrium and the content of endocrine cells in its parenchyma].
Lomakina II; Serezhin BS; Skripnik SV; Smirnov OA
Vopr Onkol; 1985; 31(8):61-7. PubMed ID: 2863893
[TBL] [Abstract][Full Text] [Related]
11. Minimal uterine serous carcinoma: current concepts in diagnosis and prognosis.
Rabban JT; Zaloudek CJ
Pathology; 2007 Feb; 39(1):125-33. PubMed ID: 17365828
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical overexpression of p16 and p53 in uterine serous carcinoma and ovarian high-grade serous carcinoma.
Chiesa-Vottero AG; Malpica A; Deavers MT; Broaddus R; Nuovo GJ; Silva EG
Int J Gynecol Pathol; 2007 Jul; 26(3):328-33. PubMed ID: 17581420
[TBL] [Abstract][Full Text] [Related]
13. Widespread psammoma body formation arising in the background of a uterine serous carcinoma.
Salmons NA
Int J Surg Pathol; 2014 Feb; 22(1):83-6. PubMed ID: 24284131
[TBL] [Abstract][Full Text] [Related]
14. [The effect of extracts from Fallopian tube tissues, uterine fibromas and uterine adenocarcinomas on the growth and capacity for cell division of a human cell line].
Kochergina NI
Tsitologiia; 1976 Jan; 18(1):106-9. PubMed ID: 941268
[TBL] [Abstract][Full Text] [Related]
15. The controversies surrounding the management of uterine serous carcinoma.
Munkarah AR
Cancer; 2004 Nov; 101(10):2152-4. PubMed ID: 15389471
[No Abstract] [Full Text] [Related]
16. Uterine papillary serous carcinoma: what have we learned over the past quarter century?
Goff BA
Gynecol Oncol; 2005 Sep; 98(3):341-3. PubMed ID: 16111527
[No Abstract] [Full Text] [Related]
17. Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma.
Vaidya AP; Horowitz NS; Oliva E; Halpern EF; Duska LR
Gynecol Oncol; 2006 Nov; 103(2):684-7. PubMed ID: 16797683
[TBL] [Abstract][Full Text] [Related]
18. Serous adenocarcinoma of the uterus presenting as paraneoplastic cerebellar degeneration.
Johns JB; Odunsi KO; Fleischman S; Azodi M; Schwartz PE
Gynecol Oncol; 1999 May; 73(2):326-30. PubMed ID: 10329056
[TBL] [Abstract][Full Text] [Related]
19. Serous papillary adenocarcinoma of the female genital organs and invasive micropapillary carcinoma of the breast. Are WT1, CA125, and GCDFP-15 useful in differential diagnosis?
Moritani S; Ichihara S; Hasegawa M; Endo T; Oiwa M; Yoshikawa K; Sato Y; Aoyama H; Hayashi T; Kushima R
Hum Pathol; 2008 May; 39(5):666-71. PubMed ID: 18339419
[TBL] [Abstract][Full Text] [Related]
20. [Construction and utilization of the prognostic model of serous ovarian adenocarcinoma].
Yang R; Feng J; Fang XZ; Bai F; Cheng YX; Liu C; Zhu W; Li L
Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):459-63. PubMed ID: 17083811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
